Your browser doesn't support javascript.
loading
Aspirin Instead of Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Risk for Stroke.
Hsu, Jonathan C; Maddox, Thomas M; Kennedy, Kevin; Katz, David F; Marzec, Lucas N; Lubitz, Steven A; Gehi, Anil K; Turakhia, Mintu P; Marcus, Gregory M.
Afiliação
  • Hsu JC; Cardiac Electrophysiology Section, Division of Cardiology, Department of Medicine, University of California, San Diego, La Jolla, California. Electronic address: Jonathan.Hsu@ucsd.edu.
  • Maddox TM; VA Eastern Colorado Health Care System/University of Colorado School of Medicine, Denver, Colorado.
  • Kennedy K; Mid America Heart Institute, Kansas City, Missouri.
  • Katz DF; University of Colorado School of Medicine, Denver, Colorado.
  • Marzec LN; University of Colorado School of Medicine, Denver, Colorado.
  • Lubitz SA; Cardiac Arrhythmia Service and Cardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts.
  • Gehi AK; University of North Carolina, Chapel Hill, North Carolina.
  • Turakhia MP; VA Palo Alto Health Care System/Stanford University School of Medicine, Palo Alto, California.
  • Marcus GM; Section of Cardiac Electrophysiology, Division of Cardiology, Department of Medicine, University of California, San Francisco, San Francisco, California.
J Am Coll Cardiol ; 67(25): 2913-23, 2016 06 28.
Article em En | MEDLINE | ID: mdl-27339487
BACKGROUND: Oral anticoagulation (OAC), rather than aspirin, is recommended in patients with atrial fibrillation (AF) at moderate to high risk of stroke. OBJECTIVES: This study sought to examine patient and practice-level factors associated with prescription of aspirin alone compared with OAC in AF patients at intermediate to high stroke risk in real-world cardiology practices. METHODS: The authors identified 2 cohorts of outpatients with AF and intermediate to high thromboembolic risk (CHADS2 score ≥2 and CHA2DS2-VASc ≥2) enrolled in the American College of Cardiology PINNACLE (Practice Innovation and Clinical Excellence) registry between 2008 and 2012. Using hierarchical modified Poisson regression models adjusted for patient and practice characteristics, the authors examined the prevalence and predictors of aspirin alone versus OAC prescription in AF patients at risk for stroke. RESULTS: Of 210,380 identified patients with CHADS2 score ≥2 on antithrombotic therapy, 80,371 (38.2%) were treated with aspirin alone, and 130,009 (61.8%) were treated with warfarin or non-vitamin K antagonist OACs. In the cohort of 294,642 patients with CHA2DS2-VASc ≥2, 118,398 (40.2%) were treated with aspirin alone, and 176,244 (59.8%) were treated with warfarin or non-vitamin K antagonist OACs. After multivariable adjustment, hypertension, dyslipidemia, coronary artery disease, prior myocardial infarction, unstable and stable angina, recent coronary artery bypass graft, and peripheral arterial disease were associated with prescription of aspirin only, whereas male sex, higher body mass index, prior stroke/transient ischemic attack, prior systemic embolism, and congestive heart failure were associated with more frequent prescription of OAC. CONCLUSIONS: In a large, real-world cardiac outpatient population of AF patients with a moderate to high risk of stroke, more than 1 in 3 were treated with aspirin alone without OAC. Specific patient characteristics predicted prescription of aspirin therapy over OAC.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Aspirina / Acidente Vascular Cerebral / Fibrinolíticos Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: J Am Coll Cardiol Ano de publicação: 2016 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Aspirina / Acidente Vascular Cerebral / Fibrinolíticos Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: J Am Coll Cardiol Ano de publicação: 2016 Tipo de documento: Article País de publicação: Estados Unidos